The safety and pharmacokinetics of ABI-4334, a novel next-generation HBV core inhibitor: interim results from a phase 1 study in healthy volunteers

被引：0
|
作者：
Gane, Edward J. [1 ]
Schwabe, Christian [2 ]
Liu, Jieming [3 ]
Stamm, Luisa M. [3 ]
Kitrinos, Kathryn M. [3 ]
Knox, Steven J. [3 ]
Anderson, Michele [3 ]
Wang, Grace [3 ]
Zomorodi, Katie [3 ]
机构：
[1] Univ Auckland, Auckland, New Zealand
[2] New Zealand Clin Res, Auckland, New Zealand
[3] Assembly Biosci, San Francisco, CA USA
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-186
引用
收藏
页码：S1161 / S1162
页数：2
相关论文
共 50 条
  • [31] OCE-205, A Novel, Selective Vasopressin Receptor Mixed Agonist-Antagonist: Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics from a Phase 1 Study in Healthy Volunteers
    Yu Bagger
    William R. Ravis
    Geoff Harris
    Stan Bukofzer
    Clinical Drug Investigation, 2023, 43 : 709 - 717
  • [32] A phase I, randomized, ascending-dose study to assess safety, pharmacokinetics, and activity of GDC-8264, a RIP1 inhibitor, in healthy volunteers
    Jones, Nicholas S.
    Kshirsagar, Smita
    Mohanan, Vishnu
    Ramakrishnan, Vidya
    Di Nucci, Flavia
    Ma, Ling
    Mao, Jialin
    Ding, Hao
    Klabunde, Sha
    Vucic, Domagoj
    Pan, Lin
    Lekkerkerker, Annemarie N.
    Chen, Yuan
    Rothenberg, Michael E.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (10): : 1997 - 2009
  • [33] Phase 1 studies to assess the safety, tolerability and pharmacokinetics of JTE-052 (a novel Janus kinase inhibitor) ointment in Japanese healthy volunteers and patients with atopic dermatitis
    Nakagawa, Hidemi
    Nemoto, Osamu
    Yamada, Hiroyuki
    Nagata, Takeshi
    Ninomiya, Noriko
    JOURNAL OF DERMATOLOGY, 2018, 45 (06): : 701 - 709
  • [34] Pharmacodynamic Results from Phase 1 Studies of GBT021601, a Next-Generation HbS Polymerization Inhibitor for Treatment of Sickle Cell Disease
    Idowu, Modupe
    Thinh Nguyen
    Lewis, Derek
    Lipato, Thokozeni
    Buckley, Erin M.
    Brothers, Rowan
    Akbar, Mariam
    Triplett, Sydney
    Dufu, Kobina
    Lisbon, Eleanor
    BLOOD, 2022, 140
  • [35] Pirtobrutinib, a Next-Generation, Highly Selective, Noncovalent BTK Inhibitor in Previously Treated Mantle Cell Lymphoma: Updated Results From the Phase 1/2 BRUIN Study
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (02) : 10 - 11
  • [36] Results of a safety, tolerability and pharmacokinetic phase I study of VCH-916, a novel polymerase inhibitor for HCV, following single ascending doses in healthy volunteers
    Proulx, L.
    Bourgault, B.
    Chauret, N.
    Larouche, R.
    Tanguay, M.
    Thibert, R.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S320 - S321
  • [37] Safety and Pharmacokinetics of the HIV-1 Protease Inhibitor TMC310911 Coadministered With Ritonavir in Healthy Participants: Results From 2 Phase 1 Studies
    Hoetelmans, Richard M. W.
    Dierynck, Inge
    Smyej, Ilham
    Meyvisch, Paul
    Jacquemyn, Bert
    Marien, Kris
    Simmen, Kenneth
    Verloes, Rene
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 65 (03) : 299 - 305
  • [38] Safety, Pharmacokinetics, and Pharmacodynamics Of SAN-300, a Novel Monoclonal Antibody Against Very Late Antigen-1: Results Of a Phase 1 Study In Healthy Volunteers and Patients With Active Rheumatoid Arthritis.
    Inderjeeth, Charles
    Redfern, Andrew
    Huang, Michael
    Hardiman, Yun
    Grant, Theresa
    Fritz, Lawrence C.
    Fuller, David
    Haughey, David
    Totoritis, Mark C.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S610 - S610
  • [39] Initial Results from a Phase 1 Clinical Study of bb21217, a Next-Generation Anti Bcma CAR T Therapy
    Shah, Nina
    Alsina, Melissa
    Siegel, David S.
    Jagannath, Sundar
    Madduri, Deepu
    Kaufman, Jonathan L.
    Turka, Ashley
    Lam, Lyh Ping
    Massaro, Monica
    Hege, Kristen
    Petrocca, Fabio
    Berdeja, Jesus G.
    Raje, Noopur
    BLOOD, 2018, 132
  • [40] Antiviral activity, pharmacokinetics and safety of the second-generation hepatitis B core inhibitor ABI-H2158 in Phase 1b study of patients with HBeAg-positive chronic hepatitis B infection
    Agarwal, Kosh
    Niu, Junqi
    Ding, Yanhua
    Gane, Edward
    Tuan Nguyen
    Alves, Katia
    Evanchick, Marc
    Zayed, Hany
    Huang, Qi
    Knox, Steven
    Stamm, Luisa
    Colonno, Richard
    Hassanein, Tarek
    Kim, Dong Joon
    Lim, Young-Suk
    Yuen, Man-Fung
    JOURNAL OF HEPATOLOGY, 2020, 73 : S125 - S125
12345